MedMira (MedMira) FCF Yield % : -3.00 (As of May. 22, 2024)

View and export this data going back to . Start your Free Trial

What is MedMira FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, MedMira's Trailing 12-Month Free Cash Flow is $-1.48 Mil, and Market Cap is $48.93 Mil. Therefore, MedMira's FCF Yield % for today is -3.00%.

The historical rank and industry rank for MedMira's FCF Yield % or its related term are showing as below:

MMIRF' s FCF Yield % Range Over the Past 10 Years
Min: -30.5 Med: -10.17 Max: 0.26
Current: -3

During the past 13 years, the highest FCF Yield % of MedMira was 0.26%. The lowest was -30.50%. And the median was -10.17%.

MMIRF's FCF Yield % is ranked better than
76.86% of 1556 companies
in the Biotechnology industry
Industry Median: -14.16 vs MMIRF: -3.00

MedMira's FCF Margin % for the quarter that ended in Jan. 2024 was -362.16%.

MedMira FCF Yield % Historical Data

The historical data trend for MedMira's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMira FCF Yield % Chart

MedMira Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

FCF Yield %

Get a 7-Day Free Trial

-0.11

-0.69

-2.17

-2.28

MedMira Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
FCF Yield %	Get a 7-Day Free Trial															-1.25	-3.13	-2.12	-23.70	-6.55

Competitive Comparison of MedMira's FCF Yield %

For the Biotechnology subindustry, MedMira's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MedMira's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MedMira's FCF Yield % distribution charts can be found below:

* The bar in red indicates where MedMira's FCF Yield % falls into.

MedMira FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

MedMira's FCF Yield % for the fiscal year that ended in Jul. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-0.961	/	42.195483
	=	-2.28%

MedMira's annualized FCF Yield % for the quarter that ended in Jan. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-0.402	*	4	/	24.560585
	=	-6.55%

MedMira FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

MedMira FCF Yield % Related Terms

Thank you for viewing the detailed overview of MedMira's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

MedMira (MedMira) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MedMira Inc (OTCPK:MMIRF) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

47M:Germany MIR:Canada

Address

155 Chain Lake Drive, Suite 1, Halifax, NS, CAN, B3S 1B3

Website

https://www.medmira.com

MedMira Inc is a biotechnology company that is engaged in the business of research, development, and manufacturing of rapid diagnostics and technologies. The company has one reportable operating segment, rapid diagnostic products and services. The product line of the company includes RevealHIV which detects antibodies to HIV-1 and HIV-2 in whole blood, serum or plasma; H Pylori which detects antibodies in serum, plasma, and whole blood; syphilis which detects treponema pallidum antibodies in serum, plasma, and whole blood; among other products. The company generates revenue geographically from North America, Europe, Asia pacific. The majority of the revenue is generated from North America.